Lumos Pharma | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Celldex Therapeutics USD 702.98M 44.02M 2025-03
Cipla INR 311.93B 27.38B 2025-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 54.91M 5.57M 2024-12
CSL USD 20.55B 3.18B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Grifols EUR 5.88B 533.83M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Merck USD 48.34B 2.02B 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Prothena USD 486.93M 47.44M 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03



Lumos Pharma Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.